Configure Azitra Completes Enrollment in Clinical Trial of Topical Commensal Microbiological Agent

Azitra, Inc., a company developing microbiome-based cosmetics and therapeutics to treat skin diseases and conditions, announced today that enrollment has been completed for the first human safety study of AZT-04. AZT-04 is the Company’s lead product candidate and is in development for cosmetic use and select therapeutic indications.